Clinical Trials on Kidney Transplantation in Switzerland

Total 286 results

Novartis

Completed

Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy

Liver Transplantation | Kidney Transplantation

Switzerland
University Hospital Inselspital, Berne
Bern University of Applied Sciences

Terminated

Whole-body Vibration Physiotherapy in Kidney Transplantation

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Withdrawn

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients (HERMES)

Kidney Transplantation

Switzerland
Novartis

Completed

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients

Kidney Transplantation

Switzerland
University Hospital, Basel, Switzerland

Completed

Comparison of ATG to Thymoglobuline in Renal Transplantation

Transplantation, Kidney

Switzerland
Novartis

Completed

Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients

Kidney Transplantation

Switzerland
University Hospital, Basel, Switzerland

Completed

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Kidney Transplantation

Switzerland
University of Zurich

Completed

Effectiveness of an APN-led Self-management Program in Patients in the First Year After Renal Transplantation (SMP-NEP)

Kidney Transplantation | Rental Transplantation

Switzerland
Novartis

Completed

Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

Kidney Transplantation | Adverse Effects

Switzerland
Novartis

Completed

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Kidney Transplantation

Switzerland
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate FK778 in Kidney Transplant Patients

Kidney Transplantation | Renal Transplantation | Transplantation, Kidney | Grafting, Kidney | Transplantation, Renal

Belgium, Germany, Spain, Sweden, Italy, Switzerland, United Kingdom, Austria, France, Poland, Czech Republic, Netherlands
Novartis Pharmaceuticals

Completed

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Kidney Transplantation

Germany, Switzerland
University of Zurich

Recruiting

Multiparametric MRI for Assessment of Changes of Renal Hemodynamics After Fistula Closure in Kidney Transplant Patients (FISCLO)

Kidney Transplantation

Switzerland
University Hospital, Basel, Switzerland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Calcineurin Free Immunosuppression in Renal Transplant Recipients

Chronic Kidney Disease | Kidney Transplantation

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN (EU-TRAIN)

Kidney Transplantation | Kidney Transplant Rejection | Prognosis | Risk Stratification

France, Germany, Spain, Switzerland
University Hospital Inselspital, Berne

Completed

Short Transverse Versus Conventional Hockey Stick Incision in Kidney Transplantation

Kidney Transplantation

Switzerland
University Hospital Inselspital, Berne

Completed

Evaluation of CAF22 After Renal Transplantation

Kidney Transplantation | Delayed Graft Function

Germany, Switzerland
Novartis Pharmaceuticals

Terminated

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Kidney Transplantation

Spain, Germany, Switzerland, Italy, United Kingdom, France, United States, Canada
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients (AEB071)

Kidney Transplantation

Germany, Switzerland, Singapore, Colombia, Argentina, Slovakia, Australia, Austria, Belgium, Brazil, Czech Republic, France, Italy, Netherlands, Norway, Spain, Taiwan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Kidney Transplantation

France, Germany, United Kingdom, Spain, Switzerland, United States, Canada, Italy
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation. (SENIOR)

Kidney Transplantation

Belgium, France, Germany, Spain, Switzerland, United Kingdom, Netherlands
Astellas Pharma Europe Ltd.

Completed

Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

Liver Transplantation | Kidney Transplantation | Heart Transplantation

Spain, Australia, France, Germany, Canada, Italy, United Kingdom, Belgium, South Africa, Switzerland, Sweden, United States, Austria, Brazil, Czechia, Denmark, Finland, Hungary, Ireland, Mexico, Netherlands, New Zealand, Poland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Kidney Transplantation

Belgium, Taiwan, Italy, Germany, Spain, Switzerland, Australia, Singapore, Norway, Netherlands, Colombia, Argentina, Brazil, Austria, Slovakia, France, Czech Republic
University Hospital Inselspital, Berne

Active, not recruiting

Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy

Kidney Transplantation | Urinary Calculi

Switzerland
Astellas Pharma Inc

Completed

A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

Kidney Transplantation

Australia, France, United Kingdom, Germany, Spain, Argentina, South Africa, Switzerland, Canada, Finland, Greece, Netherlands, Brazil, Belgium, Poland, Hungary, Czech Republic, Austria, Ireland, Italy, Mexico, Norway, Sweden
University Hospital, Geneva

Recruiting

Precision Dosing of Busulfan in Children Undergoing HSCT (BuGenes01)

Allogeneic Hematopoietic Stem Cell Transplantation | Hematopoietic Stem Cell Transplantation | Autologous Hematopoietic Stem Cell Transplantation

Switzerland
Astellas Pharma Inc

Completed

A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection (OSAKA)

Kidney Transplantation

Belgium, France, Germany, Italy, Spain, Greece, Switzerland, United Kingdom, Ireland, South Africa, Romania, Sweden, Russian Federation, Austria, Hungary, Poland, Portugal, Netherlands, Argentina, Czechia, Norway, Slovakia
Bristol-Myers Squibb

Completed

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Kidney Transplantation

Germany, United States, Colombia, Austria, Netherlands, France, Switzerland, Argentina, Norway, Sweden
University of Zurich

Completed

Preserve-Transplant Study

Renal Insufficiency | Kidney Transplantation | Acidosis

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Renal Transplantation

Switzerland
Novartis

Completed

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Renal Transplantation

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation; Swiss Heart Foundation

Completed

Absolute Myocardial Perfusion Measurement in the Transplanted Heart

Cardiac Transplantation

Switzerland
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Renal Transplantation

Switzerland
University Hospital Inselspital, Berne

Completed

A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation?

Renal Failure | Renal Transplantation | Living Donors

Switzerland
University of Basel
University Hospital, Geneva; KU Leuven; University Hospital, Basel, Switzerland; University Hospital, Zürich and other collaborators

Active, not recruiting

Implementation and Testing of an eHealth Integrated Model of Care for Patients Receiving Allogeneic Stem Cell Transplantation: The SMILe Project

Stem Cell Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

Heart Transplantation

Germany, Switzerland
University Children's Hospital, Zurich
University of Zurich

Recruiting

Clinical and Histological Study of a Novel Dermal Substitute

Skin Transplantation

Switzerland
University of Zurich

Completed

Caphosol® Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol®

Allogeneic Stem Cell Transplantation

Switzerland
University of Zurich

Unknown

Is Self-Reported Quality Assessment in Surgery Reliable?

Patients of Visceral- and Transplantation Surgery

Switzerland
Novartis

Completed

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland, Germany
University of Zurich
University of California, Los Angeles; University of Bologna; University of Southern... and other collaborators

Completed

Arterial Patency in Liver Transplantation

Liver Transplantation | Aortohepatic Conduit | Patency Rate

Switzerland
University Hospital, Basel, Switzerland

Completed

Role of Interferon-λ and Vaccine Response

Allogeneic Stem Cell Transplantation | Vaccine Response Impaired

Switzerland
University of Zurich

Unknown

Association of the Intrarenal Resistance Index (RI) of Transplanted Kidneys With Generalized Atherosclerosis

Renal Transplantation

Switzerland
Michael Scharl

Recruiting

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

Cancer | Immunotherapy | Immune Checkpoint Inhibitors | Fecal Microbiota Transplantation

Switzerland
Novartis

Completed

Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation

de Novo Liver Transplantation

Germany, Italy, Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland

Clinical Trials on Kidney Transplantation in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations